| Cadila Pharmaceuticals Ltd +1 co-filer10% owner · 3 transactions | — | 9.50Mas of Mar 2014 | — | — | 3.00M |
| Monath Thomas PDirector · 2 transactions | — | 3.23M†as of Jul 2008 | — | 358.8K | — |
| Tananbaum James BDirector · 1 transaction | — | 3.15Mas of Jul 2008 | — | 35.2K | — |
| Modi Rajiv I.Director · 17 transactions | — | 2.50Mas of Jun 2015 | — | — | 10.00M |
| Jacobs John CPresident and CEO, Director · 10 transactions | — | 225.7K | 483.1K | — | — |
| Odonnell Denis MDirector · 2 transactions | — | 221.5Kas of Mar 2006 | — | — | 231.6K |
| Boudreaux GailDirector · 1 transaction | — | 200.0Kas of Sep 2016 | — | 100.0K | — |
| O'Hara ElaineEVP, Chief Strategy Officer · 8 transactions | — | 157.1K | 135.5K | — | — |
| Hage Raymond JosephSr. VP. Commercial Operations · 23 transactions | — | 140.2Kas of Jul 2009 | 100.0K | — | 208.8K |
| Kelly James PatrickEVP, CFO and Treasurer · 22 transactions | — | 130.6K | 189.8K | — | — |
| Robinson JimVP, Tech. & Quality Operations · 4 transactions | — | 113.7K†as of Jul 2008 | — | 42.6K | — |
| Singhvi RahulPresident, CEO, Director · 16 transactions | — | 113.1Kas of Jul 2009 | 200.0K | 11.7K | 258.3K |
| Hahn Timothy JonSVP, Manufacturing · 8 transactions | — | 110.5Kas of Jan 2015 | — | 90.5K | — |
| Lambert John ADirector · 11 transactions | — | 105.9Kas of Jul 2009 | 100.0K | 14.7K | 34.7K |
| Casey Mark JEVP, Chief Legal Officer · 8 transactions | — | 101.4K | 125.3K | — | — |
| Kelly Mitchell JDirector · 2 transactions | — | 95.5K†as of Mar 2006 | — | — | 1.74M |
| Trizzino JohnPresident and COO · 256 transactions | — | 82.0Kas of Mar 2025 | 303.4K | 159.0K | 151.9K |
| Mott David MDirector · 10 transactions | — | 79.8K | 39.8K | — | 25.0K |
| Douglas RichardDirector · 15 transactions | — | 73.2K | 45.7K | 550.0K | — |
| Dubovsky FilipPresident, R&D · 18 transactions | — | 66.6Kas of Jun 2024 | 79.4K | — | 61.2K |
| Wilson Russell PSVP, Business Development · 3 transactions | — | 64.9Kas of Jan 2015 | — | 14.9K | — |
| Young James FDirector · 34 transactions | — | 51.8Kas of Dec 2024 | 112.5K | 426.5K | 387.3K |
| Alton Gregg HDirector · 9 transactions | — | 47.7K | 47.7K | — | — |
| Rodgers Richard JDirector · 6 transactions | — | 47.4K | 47.4K | — | — |
| McGlynn Margaret GDirector · 9 transactions | — | 44.5K | 44.5K | — | — |
| King Rachel K.Director · 11 transactions | — | 44.1K | 43.2K | 86.7K | 4.2K |
| Phillips Barclay ASVP, Chief Financial Officer · 14 transactions | — | 38.7Kas of Jul 2017 | — | 67.3K | 28.7K |
| Erck Stanley CPresident and CEO, Director · 128 transactions | — | 36.5Kas of Dec 2022 | 739.0K | 353.1K | 715.4K |
| Evans Gary CDirector · 32 transactions | — | 36.3K†as of Jun 2021 | 372.9K | 230.8K | 967.2K |
| Johnston Thomas ScottVice President, Strategy · 3 transactions | — | 23.8Kas of Jul 2009 | — | 1.0K | 15.0K |
| Hall PatriciaChief Accounting Officer · 6 transactions | — | 21.0Kas of Oct 2006 | 20.3K | — | — |
| Stigliano Len FVP, CFO, Treasurer · 2 transactions | — | 20.6Kas of Jul 2008 | — | 20.6K | — |
| Driscoll Frederick WVP, CFO & Treasurer · 2 transactions | — | 20.0Kas of Aug 2011 | 10.0K | 20.0K | — |
| Heaton PennyVP & Chief Medical Officer · 4 transactions | — | 18.7Kas of Jul 2009 | — | 3.8K | 8.3K |
| Glenn Gregory MPresident, R&D · 483 transactions | — | 18.3Kas of Mar 2023 | 404.1K | 133.1K | 454.1K |
| Herrmann John A IIIEVP, Chief Legal Officer · 247 transactions | — | 17.3K†as of Dec 2023 | 228.3K | 27.4K | 211.0K |
| Draghia-Akli RuxandraSection 16 · 2 transactions | — | 14.3K | 14.3K | — | — |
| Lazarus J Michael MDDirector · 2 transactions | — | 11.9Kas of Dec 2005 | 10.0K | — | 10.0K |
| McManus Michael A JrDirector · 19 transactions | — | 10.1Kas of Jun 2022 | 152.2K | 77.6K | 15.9K |
| Newton Charles W.Director · 1 transaction | — | 9.5K | 9.5K | — | — |
| Shiver John W.Director · 1 transaction | — | 7.9K | 7.9K | — | — |
| Genge Dennis WVP, Treasurer,CFO · 1 transaction | — | 6.4Kas of Feb 2006 | 25.0K | — | — |